Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-02-02 Sale |
2021-02-03 5:09 pm |
Mirati Therapeutics Inc. | MRTX | Faga Daniel EVP, Chief Operating Officer |
1,340 | $194.38 | $260,469 | 94,268 (Direct) |
View |
| 2021-02-02 Sale |
2021-02-03 5:08 pm |
Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director |
2,250 | $191.12 | $430,018 | 5,725 (Direct) |
View |
| 2021-01-29 Sale |
2021-02-01 9:47 pm |
Mirati Therapeutics Inc. | MRTX | Martinez Maria E Director |
7,500 | $203.54 | $1,526,584 | 20,975 (Direct) |
View |
| 2021-01-21 Sale |
2021-01-25 4:31 pm |
Mirati Therapeutics Inc. | MRTX | Johnson Craig A Director |
15,000 | $211.55 | $3,173,203 | 3,475 (Direct) |
View |
| 2021-01-06 Sale |
2021-01-08 7:57 pm |
Mirati Therapeutics Inc. | MRTX | REED VICKIE S SVP, Chief Accounting Officer |
779 | $212.23 | $165,325 | 7,471 (Direct) |
View |
| 2021-01-07 Sale |
2021-01-08 7:46 pm |
Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer |
2,078 | $216.33 | $449,525 | 19,789 (Direct) |
View |
| 2021-01-06 Sale |
2021-01-08 7:15 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
1,459 | $210.39 | $306,961 | 47,262 (Direct) |
View |
| 2021-01-07 Sale |
2021-01-08 7:15 pm |
Mirati Therapeutics Inc. | MRTX | Faga Daniel EVP, Chief Operating Officer |
2,625 | $216.33 | $567,854 | 23,615 (Direct) |
View |
| 2021-01-06 Sale |
2021-01-08 7:14 pm |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President & CEO |
4,511 | $210.39 | $949,066 | 87,512 (Direct) |
View |
| 2020-12-18 Sale |
2020-12-21 6:28 pm |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President & CEO |
40,000 | $234.48 | $9,379,114 | 189,227 (Direct) |
View |
| 2020-12-15 Sale |
2020-12-16 5:37 pm |
Mirati Therapeutics Inc. | MRTX | FUCHS HENRY J Director |
10,000 | $233.39 | $2,333,907 | 8,000 (Direct) |
View |
| 2020-12-14 Sale |
2020-12-16 5:37 pm |
Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director |
2,250 | $246.28 | $554,127 | 6,500 (Direct) |
View |
| 2020-12-14 Sale |
2020-12-16 5:36 pm |
Mirati Therapeutics Inc. | MRTX | GREY MICHAEL G Director |
10,900 | $245.44 | $2,675,345 | 4,256 (Direct) |
View |
| 2020-10-30 Sale |
2020-10-30 9:54 pm |
Mirati Therapeutics Inc. | MRTX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. LIEBERBURG IVAN M Dissanayake Shehan Bharatha Fuglesang Christopher 10% Owner |
400,000 | $202 | $80,800,000 | 1,908,361 (Direct) |
View |
| 2020-10-28 Sale |
2020-10-30 9:53 pm |
Mirati Therapeutics Inc. | MRTX | Braslyn Ltd. LEWIS JOSEPH 10% Owner |
400,000 | $208.34 | $83,334,437 | 10,421,373 (Direct) |
View |
| 2020-08-11 Sale |
2020-08-13 4:03 pm |
Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director |
2,250 | $126.41 | $284,428 | 8,750 (Direct) |
View |
| 2020-08-10 Sale |
2020-08-11 5:36 pm |
Mirati Therapeutics Inc. | MRTX | FUCHS HENRY J Director |
10,000 | $131.38 | $1,313,783 | 7,000 (Direct) |
View |
| 2020-06-12 Sale(A) |
2020-06-16 7:09 pm |
Mirati Therapeutics Inc. | MRTX | Braslyn Ltd. 10% Owner |
600,000 | $97 | $58,200,000 | 7,126,386 (Direct) |
View |
| 2020-06-12 Sale |
2020-06-16 5:03 pm |
Mirati Therapeutics Inc. | MRTX | Braslyn Ltd. 10% Owner |
600,000 | $69 | $41,400,000 | 7,126,386 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-02-02 Exercise |
2021-02-03 5:09 pm |
N/A 2030-01-05 |
Mirati Therapeutics Inc. | MRTX | Faga Daniel EVP, Chief Operating Officer |
1,340 | $0 | 94,268 (Direct) |
View |
| 2021-02-02 Exercise |
2021-02-03 5:09 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Faga Daniel EVP, Chief Operating Officer |
1,340 | $114.33 | 94,268 (Direct) |
View |
| 2021-02-02 Exercise |
2021-02-03 5:08 pm |
2019-09-27 2026-09-26 |
Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director |
2,250 | $0 | 5,725 (Direct) |
View |
| 2021-02-02 Exercise |
2021-02-03 5:08 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director |
2,250 | $6.78 | 5,725 (Direct) |
View |
| 2021-01-29 Exercise |
2021-02-01 9:47 pm |
N/A 2028-12-05 |
Mirati Therapeutics Inc. | MRTX | Martinez Maria E Director |
7,500 | $0 | 20,975 (Direct) |
View |
| 2021-01-29 Exercise |
2021-02-01 9:47 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Martinez Maria E Director |
7,500 | $39.76 | 20,975 (Direct) |
View |
| 2021-01-26 Exercise |
2021-01-28 5:45 pm |
N/A 2027-01-25 |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President & CEO |
2,292 | $0 | 212,987 (Direct) |
View |
| 2021-01-26 Exercise |
2021-01-28 5:45 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President & CEO |
2,292 | $5.4 | 212,987 (Direct) |
View |
| 2021-01-21 Exercise |
2021-01-25 4:31 pm |
N/A 2024-09-08 |
Mirati Therapeutics Inc. | MRTX | Johnson Craig A Director |
15,000 | $0 | 3,475 (Direct) |
View |
| 2021-01-21 Exercise |
2021-01-25 4:31 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Johnson Craig A Director |
15,000 | $20.54 | 3,475 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 6:18 pm |
N/A 2031-01-14 |
Mirati Therapeutics Inc. | MRTX | REED VICKIE S SVP, Chief Accounting Officer |
10,656 | $0 | 18,127 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 6:18 pm |
N/A 2031-01-14 |
Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer |
18,002 | $0 | 37,791 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 6:18 pm |
N/A 2031-01-14 |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
18,002 | $0 | 65,264 (Direct) |
View |
| 2021-01-19 Exercise |
2021-01-20 6:17 pm |
N/A 2028-01-17 |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President & CEO |
3,245 | $0 | 322,919 (Direct) |
View |
| 2021-01-19 Exercise |
2021-01-20 6:17 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President & CEO |
3,245 | $27 | 322,919 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 6:17 pm |
N/A 2031-01-14 |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President & CEO |
50,407 | $0 | 322,919 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 6:17 pm |
N/A 2031-01-14 |
Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director |
3,630 | $0 | 5,630 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 6:17 pm |
N/A 2031-01-14 |
Mirati Therapeutics Inc. | MRTX | Martinez Maria E Director |
3,630 | $0 | 5,630 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 6:16 pm |
N/A 2031-01-14 |
Mirati Therapeutics Inc. | MRTX | FUCHS HENRY J Director |
3,630 | $0 | 5,630 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 6:16 pm |
N/A 2031-01-14 |
Mirati Therapeutics Inc. | MRTX | GREY MICHAEL G Director |
3,630 | $0 | 7,886 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 6:15 pm |
N/A 2031-01-14 |
Mirati Therapeutics Inc. | MRTX | Johnson Craig A Director |
3,630 | $0 | 5,630 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 6:15 pm |
N/A 2031-01-14 |
Mirati Therapeutics Inc. | MRTX | Cherrington Julie M Director |
3,630 | $0 | 5,630 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 6:15 pm |
N/A 2031-01-14 |
Mirati Therapeutics Inc. | MRTX | Davis Aaron I. Director 10% Owner |
3,630 | $0 | 42,682 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 6:14 pm |
N/A 2031-01-14 |
Mirati Therapeutics Inc. | MRTX | Hasnain Faheem Director |
5,162 | $0 | 8,162 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 6:14 pm |
N/A 2031-01-14 |
Mirati Therapeutics Inc. | MRTX | Faga Daniel EVP, Chief Operating Officer |
18,002 | $0 | 41,617 (Direct) |
View |
| 2020-12-29 Gift |
2020-12-31 6:39 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President & CEO |
10,000 | $0 | 92,023 (Direct) |
View |
| 2020-12-18 Exercise |
2020-12-21 6:28 pm |
2017-05-09 2022-11-12 |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President & CEO |
40,000 | $0 | 189,227 (Direct) |
View |
| 2020-12-18 Exercise |
2020-12-21 6:28 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President & CEO |
40,000 | $8.49 | 189,227 (Direct) |
View |
| 2020-12-15 Exercise |
2020-12-16 5:37 pm |
2017-09-09 2024-09-08 |
Mirati Therapeutics Inc. | MRTX | FUCHS HENRY J Director |
10,000 | $0 | 8,000 (Direct) |
View |
| 2020-12-15 Exercise |
2020-12-16 5:37 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | FUCHS HENRY J Director |
10,000 | $20.54 | 8,000 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-16 5:37 pm |
2019-09-27 2026-09-26 |
Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director |
2,250 | $0 | 6,500 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-16 5:37 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director |
2,250 | $6.78 | 6,500 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-16 5:36 pm |
2017-11-05 2024-11-04 |
Mirati Therapeutics Inc. | MRTX | GREY MICHAEL G Director |
10,900 | $0 | 4,256 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-16 5:36 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | GREY MICHAEL G Director |
10,900 | $16.84 | 4,256 (Direct) |
View |
| 2020-11-02 Option Award(A) |
2020-11-12 6:21 pm |
N/A 2030-11-01 |
Mirati Therapeutics Inc. | MRTX | REED VICKIE S SVP, Chief Accounting Officer |
2,522 | $0 | 2,522 (Direct) |
View |
| 2020-11-02 Option Award |
2020-11-06 7:35 pm |
N/A 2030-11-01 |
Mirati Therapeutics Inc. | MRTX | REED VICKIE S SVP, Chief Accounting Officer |
2,523 | $0 | 2,523 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-04 5:59 pm |
N/A 2026-01-21 |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
10,879 | $0 | 120,050 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-04 5:59 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
1,595 | $24.99 | 120,050 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-04 5:59 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
4,284 | $5.4 | 120,050 (Direct) |
View |
| 2020-11-02 Exercise |
2020-11-04 5:59 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
5,000 | $5.5 | 120,050 (Direct) |
View |
| 2020-10-30 Tax Withholding |
2020-10-30 9:54 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. LIEBERBURG IVAN M Dissanayake Shehan Bharatha Fuglesang Christopher 10% Owner |
3 | $219.97 | 1,908,361 (Direct) |
View |
| 2020-10-30 Exercise |
2020-10-30 9:54 pm |
2017-01-06 N/A |
Mirati Therapeutics Inc. | MRTX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. LIEBERBURG IVAN M Dissanayake Shehan Bharatha Fuglesang Christopher 10% Owner |
400,003 | $5.599 | 1,908,361 (Direct) |
View |
| 2020-10-30 Exercise |
2020-10-30 9:54 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. LIEBERBURG IVAN M Dissanayake Shehan Bharatha Fuglesang Christopher 10% Owner |
400,003 | $0.001 | 1,908,361 (Direct) |
View |
| 2020-10-28 Exercise |
2020-10-30 9:53 pm |
2017-01-06 N/A |
Mirati Therapeutics Inc. | MRTX | Braslyn Ltd. LEWIS JOSEPH 10% Owner |
400,003 | $5.599 | 10,421,373 (Direct) |
View |
| 2020-10-28 Exercise |
2020-10-30 9:53 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Braslyn Ltd. LEWIS JOSEPH 10% Owner |
400,003 | $0.001 | 10,421,373 (Direct) |
View |
| 2020-10-28 Tax Withholding |
2020-10-30 9:53 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Braslyn Ltd. LEWIS JOSEPH 10% Owner |
2 | $209.16 | 10,421,373 (Direct) |
View |
| 2020-10-29 Tax Withholding |
2020-10-30 9:53 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Braslyn Ltd. LEWIS JOSEPH 10% Owner |
1 | $202.25 | 10,421,373 (Direct) |
View |
Ownership |
2020-10-30 9:28 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Lockend Five LLC 10% Owner |
0 | $0 | 203,754 (Direct) |
View |
| 2020-08-11 Exercise |
2020-08-13 4:03 pm |
N/A 2026-09-26 |
Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director |
2,250 | $0 | 8,750 (Direct) |
View |
| 2020-08-11 Exercise |
2020-08-13 4:03 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director |
2,250 | $6.78 | 8,750 (Direct) |
View |
| 2020-08-10 Exercise |
2020-08-11 5:36 pm |
2014-09-09 2024-09-08 |
Mirati Therapeutics Inc. | MRTX | FUCHS HENRY J Director |
10,000 | $0 | 7,000 (Direct) |
View |
| 2020-08-10 Exercise |
2020-08-11 5:36 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | FUCHS HENRY J Director |
10,000 | $20.54 | 7,000 (Direct) |
View |
| 2020-07-23 Gift |
2020-07-24 5:30 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President & CEO |
5,000 | $0 | 102,023 (Direct) |
View |
| 2020-06-12 Exercise(A) |
2020-06-16 7:09 pm |
2017-01-06 N/A |
Mirati Therapeutics Inc. | MRTX | Braslyn Ltd. 10% Owner |
600,006 | $5.599 | 7,126,386 (Direct) |
View |
| 2020-06-12 Exercise(A) |
2020-06-16 7:09 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Braslyn Ltd. 10% Owner |
600,006 | $0.001 | 7,126,386 (Direct) |
View |
| 2020-06-12 Tax Withholding(A) |
2020-06-16 7:09 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Braslyn Ltd. 10% Owner |
6 | $100.69 | 7,126,386 (Direct) |
View |
| 2020-06-12 Exercise |
2020-06-16 5:03 pm |
2017-01-06 N/A |
Mirati Therapeutics Inc. | MRTX | Braslyn Ltd. 10% Owner |
600,006 | $5.599 | 7,126,386 (Direct) |
View |
| 2020-06-12 Exercise |
2020-06-16 5:03 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Braslyn Ltd. 10% Owner |
600,006 | $0.001 | 7,126,386 (Direct) |
View |
| 2020-06-12 Tax Withholding |
2020-06-16 5:03 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Braslyn Ltd. 10% Owner |
6 | $72.8 | 7,126,386 (Direct) |
View |
| 2020-05-21 Option Award |
2020-05-22 5:35 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
5,000 | $0 | 37,842 (Direct) |
View |